RxDoctor Payments Data

Katie McMinn, PA

Physician Assistant · Claremont, NCNPI 1427254986

Payments from drug & device makers

$2,704in general payments, 2019–2025

Across 158 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$705
  • AstraZeneca$354
  • Lilly USA, LLC$282
  • Pfizer$239
  • Novo Nordisk$192
  • Corcept Therapeutics$86
  • plus $846 from 24 others

What the payments were for

  • Food & beverage$2,704100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,704 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,289
Medicare patients
50
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$52,611
JardianceEmpagliflozin35$36,284
MounjaroTirzepatide24$29,606
EliquisApixaban34$23,029
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog20$18,454
FarxigaDapagliflozin Propanediol24$18,096
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,627
Tresiba Flextouch U-100Insulin Degludec12$7,482
Albuterol Sulfate HfaAlbuterol Sulfate31$858
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$855
Cefdinir43$598
Gabapentin51$554
Losartan Potassium55$415
Atorvastatin Calcium65$404
Lisinopril90$398

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$192$52,61149 claims
Boehringer IngelheimJardiance$30$36,28435 claims
Lilly USA, LLCMounjaro$282$29,60624 claims
PfizerEliquis$239$23,02934 claims
AstraZenecaFarxiga$354$18,09624 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Claremont

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →